Konsume
Interval Day Week Month
Newswire Search Past 90 Days 352 stories 59 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View

Related Topics
Topic # Mentions Topic Reach
phase40-
biotech27-
the27-
data23-
study20-
positive11-
lilly10-
financing9-
collaboration8-
develop7-
medical7-
next7-
ind6-
pipeline6-
oncology6-
ipo6-
sign6-
nda6-
rna6-
placement5-
lsd5-
concerns5-
review4-
boulder4-
strong4-
bln4-
prime4-
lytenava4-
capricor4-
duchenne4-
runway4-
blood4-
startup4-
firm4-
meet3-
milestone3-
bizwest3-
success3-
cfo3-
dmd3-
dispute3-
pharma3-
brain3-
next gen3-
launches3-
halozyme3-
Prominent Journalists
Byline Articles Written Avg Reach
RTTNews Staff Writer 107 -
By Salong Debbarma 25 -
TajSabreen Ahamed 20 -
by PR Newswire 19 -
Frank Vinluan 19 -
Prabha Kurup 18 -
Gayathry Prakash 14 -
PR Newswire 7 -
Jason Mast 6 -
Bob D'Angelo, Cox Media Group National Content Desk 5 -
Adam Feuerstein 4 -
Array 4 -
Lori DeBoer 3 -
Lucas High 3 -
David Krechevsky 2 -
Ed Cara 2 -
Frances Martel 2 -
Jeon Ji-woo 2 -
Daniel Bradley 2 -
By srivani venna 2 -


Weekly Buzz: JNJ Wins FDA Nod; AXGN, HCWB Strike Deals; ROIV, AZN, GPCR Lead Clinical Trials

rttnews.com


Allarity Acquisition Seeks Nasdaq Listing With Proposed $100 Mln IPO

RTTNews Staff Writerrttnews.com


Show Me The Money: Filspari Powers Travere Therapeutics' Growth

Prabha Kuruprttnews.com


Exegenesis Bio, Modalis sign research deal for Duchenne therapy

By Salong Debbarmapharmaceutical-business-review.com


Outlook Therapeutics Highlights LYTENAVA FDA Approval And U.S. Commercial Opportunity

RTTNews Staff Writerrttnews.com


TwoStep Therapeutics secures $62.5m to advance TS-104

By Salong Debbarmapharmaceutical-business-review.com


Clinical Catalysts Drive Biotech Movers: Opus Genetics, Quantum & More

RTTNews Staff Writerrttnews.com


Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

by PR Newswirethailand-business-news.com


Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea

Jonathan Wosenstatnews.com


FDA grants RMAT designation to RiboX’s RXRG001 for xerostomia

By Salong Debbarmapharmaceutical-business-review.com

Execution: 1.61 Seconds. 61.1 mb used.